Shi et al. used a PCR-based Taqman copy number assay to detect copy gain (>2.2) of PD-L2, and found 9 of 12 PMBCL but none of the 9 DLBCL patients had PD-L2 gain20. This evidence concerns the gene PDCD1LG2 and diffuse large B-cell lymphoma.